NKTR - Nektar Therapeutics - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - NKTR (906709)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P1-1-3+3+46
S70-0+1+10+10

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

D
2017-10-09
NKTRRobin Howard WPres, CEOS - Sale+OE$24.20-83,333152,914-35%-$2,016,659
D
2017-10-05
NKTRHora ManinderSVP Pharma Dev, Mfg OpsS - Sale+OE$25.00-7,58358,233-12%-$189,575
D
2017-10-05
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerS - Sale+OE$24.97-43,67731,102-58%-$1,090,615
D
2017-10-02
NKTRLabrucherie Gil MSVP, CFOS - Sale+OE$24.45-120,00063,414-65%-$2,934,000
DM
2017-09-29
NKTRGergel Ivan P.SVP, Chief Medical OfficerS - Sale+OE$24.14-100,00041,575-71%-$2,413,640
2017-09-22
NKTRLingnau LutzDirS - Sale$21.97-5,00027,450-15%-$109,850
2017-09-22
NKTRKuebler Christopher ADirS - Sale$21.86-4,00040,500-9%-$87,440
2017-09-21
NKTRChess RobertDirS - Sale$21.72-6,400274,223-2%-$139,008
D
2017-09-06
NKTRRobin Howard WPres, CEOS - Sale+OE$21.54-83,333152,914-35%-$1,794,993
2017-08-16
NKTRThomsen Jillian B.SVP, Chief Accounting OfficerS - Sale$19.32-2,64850,838-5%-$51,159
D
2017-08-16
NKTRRobin Howard WPres, CEOS - Sale+OE$19.26-91,714152,914-37%-$1,766,081
2017-08-16
NKTRNicholson JohnSVP, COOS - Sale$19.32-3,177224,066-1%-$61,380
2017-08-16
NKTRLabrucherie Gil MSVP, CFOS - Sale$19.32-3,17763,414-5%-$61,380
2017-08-16
NKTRHora ManinderSVP Pharma Dev, Mfg OpsS - Sale$19.32-2,95658,233-5%-$57,110
2017-08-16
NKTRGergel Ivan P.SVP, Chief Medical OfficerS - Sale$19.32-1,99741,575-5%-$38,582
2017-08-16
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerS - Sale$19.32-1,70131,102-5%-$32,863
2017-08-10
NKTRWhitfield Roy ADirP - Purchase$17.95+35,000153,000+30%+$628,250
D
2017-07-18
NKTRGergel Ivan P.SVP, Chief Medical OfficerS - Sale+OE$21.10-54,92043,572-56%-$1,158,812
D
2017-07-14
NKTRLingnau LutzDirS - Sale+OE$20.76-30,00023,450-56%-$622,800
DM
2017-07-11
NKTRGergel Ivan P.SVP, Chief Medical OfficerS - Sale+OE$21.08-45,08043,572-51%-$950,318
D
2017-06-07
NKTRNicholson JohnSVP, COOS - Sale+OE$19.24-101,700227,243-31%-$1,956,708
2017-05-16
NKTRThomsen Jillian B.SVP, Chief Accounting OfficerS - Sale$19.55-2,65152,986-5%-$51,827
2017-05-16
NKTRRobin Howard WPres, CEOS - Sale$19.55-8,388161,294-5%-$163,985
2017-05-16
NKTRNicholson JohnSVP, COOS - Sale$19.55-3,146178,943-2%-$61,504
2017-05-16
NKTRLabrucherie Gil MSVP, CFOS - Sale$19.55-3,17966,091-5%-$62,149
2017-05-16
NKTRHora ManinderSVP Pharma Dev, Mfg OpsS - Sale$19.55-2,95960,689-5%-$57,848
2017-05-16
NKTRGergel Ivan P.SVP, Chief Medical OfficerS - Sale$19.55-1,45043,572-3%-$28,348
2017-05-16
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerS - Sale$19.55-1,70132,803-5%-$33,255
D
2017-05-15
NKTRChess RobertDirS - Sale+OE$19.79-5,000271,623-2%-$98,950
D
2017-04-17
NKTRChess RobertDirS - Sale+OE$18.72-5,000271,623-2%-$93,600+3+4
2017-04-07
NKTRLingnau LutzDirS - Sale$20.05-7,00023,450-23%-$140,350-20+2
D
2017-04-05
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerS - Sale+OE$21.70-100,00034,504-74%-$2,170,000-8-7-10
D
2017-04-05
NKTRHora ManinderSVP Pharma Dev, Mfg OpsS - Sale+OE$21.70-180,00063,648-74%-$3,906,000-8-7-10
D
2017-04-05
NKTRKuebler Christopher ADirS - Sale+OE$21.88-15,00035,500-30%-$328,200-8-7-10
D
2017-03-20
NKTRThomsen Jillian B.SVP, Chief Accounting OfficerS - Sale+OE$19.69-112,50055,637-67%-$2,215,125-2+5-17
D
2017-03-14
NKTRChess RobertDirS - Sale+OE$15.41-5,000271,623-2%-$77,050-1+46+19
DM
2017-03-02
NKTRLabrucherie Gil MSVP, CFOS - Sale+OE$15.16-200,00069,270-74%-$3,031,950-2+5+60
D
2017-02-21
NKTRLingnau LutzDirS - Sale+OE$13.08-30,00030,450-50%-$392,400+2-1+71
2017-02-16
NKTRThomsen Jillian B.SVP, Chief Accounting OfficerS - Sale$13.14-1,96555,637-3%-$25,820+2+3+69
2017-02-16
NKTRRobin Howard WPres, CEOS - Sale$13.14-8,636169,682-5%-$113,477+2+3+69
2017-02-16
NKTRNicholson JohnSVP, COOS - Sale$13.14-3,237182,089-2%-$42,534+2+3+69
2017-02-16
NKTRLabrucherie Gil MSVP, CFOS - Sale$13.14-2,35969,270-3%-$30,997+2+3+69
2017-02-16
NKTRHora ManinderSVP Pharma Dev, Mfg OpsS - Sale$13.14-2,19563,648-3%-$28,842+2+3+69
2017-02-16
NKTRGergel Ivan P.SVP, Chief Medical OfficerS - Sale$13.14-1,45745,022-3%-$19,145+2+3+69
2017-02-16
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerS - Sale$13.14-1,26134,504-4%-$16,570+2+3+69
D
2017-02-08
NKTRRobin Howard WPres, CEOS - Sale+OE$13.04-87,500178,318-33%-$1,141,0000-2+18
DM
2017-02-02
NKTRNicholson JohnSVP, COOS - Sale+OE$12.39-75,000140,326-35%-$929,351-2-1+6
D
2017-01-17
NKTRRobin Howard WPres, CEOS - Sale+OE$12.35-87,500178,318-33%-$1,080,625-2+1+6
D
2016-12-07
NKTRRobin Howard WPres, CEOS - Sale+OE$12.24-87,500123,318-42%-$1,071,000-5-5+2
2016-11-16
NKTRThomsen Jillian B.SVP, Chief Accounting OfficerS - Sale$13.96-1,98642,102-5%-$27,725-3-3-7
DM
2016-11-16
NKTRRobin Howard WPres, CEOS - Sale+OE$13.88-93,458123,318-43%-$1,296,799-3-3-7
2016-11-16
NKTRNicholson JohnSVP, COOS - Sale$13.96-1,654120,326-1%-$23,090-3-3-7
2016-11-16
NKTRLabrucherie Gil MSVP, CFOS - Sale$13.96-1,65451,129-3%-$23,090-3-3-7
2016-11-16
NKTRHora ManinderSVP Pharma Dev, Mfg OpsS - Sale$13.96-1,65450,343-3%-$23,090-3-3-7
2016-11-16
NKTRGergel Ivan P.SVP, Chief Medical OfficerS - Sale$13.96-84826,479-3%-$11,838-3-3-7
2016-11-16
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerS - Sale$13.96-67018,265-4%-$9,353-3-3-7
2016-10-24
NKTRGreer R ScottDirP - Purchase$13.50+15,000121,333+14%+$202,500-1-3+3+46
D
2016-10-04
NKTRRobin Howard WPres, CEOS - Sale+OE$17.06-87,500129,276-40%-$1,492,750-1-5-30+24
D
2016-09-15
NKTRLingnau LutzDirS - Sale+OE$19.06-9,00022,450-29%-$171,5400-1-17+16
D
2016-09-16
NKTRKuebler Christopher ADirS - Sale+OE$19.13-7,50027,500-21%-$143,4750-1-17+16
D
2016-09-15
NKTRChess RobertDirS - Sale+OE$19.21-12,000263,623-4%-$230,5200-1-17+16
D
2016-09-01
NKTRRobin Howard WPres, CEOS - Sale+OE$17.83-87,500129,296-40%-$1,560,125+3+1-5-22
2016-08-16
NKTRNicholson JohnSVP, COOS - Sale$17.56-3,317121,980-3%-$58,2470+3+9-23
2016-08-16
NKTRThomsen Jillian B.SVP, Chief Accounting OfficerS - Sale$17.56-3,97144,088-8%-$69,7310+3+9-23
2016-08-16
NKTRRobin Howard WPres, CEOS - Sale$17.56-11,817129,276-8%-$207,5070+3+9-23
2016-08-16
NKTRLabrucherie Gil MSVP, CFOS - Sale$17.56-3,30552,783-6%-$58,0360+3+9-23
2016-08-16
NKTRHora ManinderSVP Pharma Dev, Mfg OpsS - Sale$17.56-3,30551,997-6%-$58,0360+3+9-23
2016-08-16
NKTRGergel Ivan P.SVP, Chief Medical OfficerS - Sale$17.56-1,68527,327-6%-$29,5890+3+9-23
2016-08-16
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerS - Sale$17.56-1,33618,935-7%-$23,4600+3+9-23
D
2016-08-01
NKTRChess RobertDirS - Sale+OE$17.26-5,000260,623-2%-$86,3000-1+2-29
D
2016-07-11
NKTRThomsen Jillian B.SVP, Chief Accounting OfficerS - Sale+OE$15.09-100,0006,809-94%-$1,509,000-1-5+8-14
D
2016-07-01
NKTRChess RobertDirS - Sale+OE$14.10-5,000260,623-2%-$70,500+1+7+21-13
D
2016-06-01
NKTRChess RobertDirS - Sale+OE$15.50-5,000260,623-2%-$77,500+3+3-9-22
D
2016-05-17
NKTRNicholson JohnSVP, CFOS - Sale+OE$13.58-85677,630-1%-$11,624-2+7+10+6
D
2016-05-17
NKTRRobin Howard WPres, CEOS - Sale+OE$13.58-2,17017,343-11%-$29,469-2+7+10+6
D
2016-05-17
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerS - Sale+OE$13.58-3391,021-25%-$4,604-2+7+10+6
D
2016-05-17
NKTRGergel Ivan P.SVP, Chief Medical OfficerS - Sale+OE$13.58-4321,512-22%-$5,867-2+7+10+6
D
2016-05-17
NKTRHora ManinderSVP Pharma Dev, Mfg OpsS - Sale+OE$13.58-8357,135-10%-$11,339-2+7+10+6
D
2016-05-17
NKTRLabrucherie Gil MSVP, GCS - Sale+OE$13.58-8367,921-10%-$11,353-2+7+10+6
D
2016-05-17
NKTRThomsen Jillian B.SVP, Chief Accounting OfficerS - Sale+OE$13.58-7246,309-10%-$9,832-2+7+10+6
D
2016-04-25
NKTRLingnau LutzDirS - Sale+OE$16.27-15,00016,450-48%-$244,050-1-4-9-19
D
2016-03-09
NKTRThomsen Jillian B.SVP, Chief Accounting OfficerS - Sale+OE$11.79-15,0005,158-74%-$176,850+1-5+20+56
D
2016-02-17
NKTRGergel Ivan P.SVP, Chief Medical OfficerS - Sale+OE$11.92-556694-44%-$6,628+10+8+52
D
2016-02-17
NKTRNicholson JohnSVP, CFOS - Sale+OE$11.92-96376,319-1%-$11,479+10+8+52
D
2016-02-17
NKTRRobin Howard WPres, CEOS - Sale+OE$11.92-2,14713,888-13%-$25,592+10+8+52
D
2016-02-17
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerS - Sale+OE$11.92-390485-45%-$4,649+10+8+52
D
2016-02-17
NKTRThomsen Jillian B.SVP, Chief Accounting OfficerS - Sale+OE$11.92-7165,158-12%-$8,535+10+8+52
D
2016-02-17
NKTRLabrucherie Gil MSVP, GCS - Sale+OE$11.92-8276,590-11%-$9,858+10+8+52
D
2016-02-17
NKTRHora ManinderSVP Pharma Dev, Mfg OpsS - Sale+OE$11.92-9635,803-14%-$11,479+10+8+52
D
2016-02-10
NKTRLabrucherie Gil MSVP, GCS - Sale+OE$11.49-11,6665,251-69%-$134,0420-1+13+50
D
2016-02-10
NKTRThomsen Jillian B.SVP, Chief Accounting OfficerS - Sale+OE$11.49-15,0003,999-79%-$172,3500-1+13+50
D
2016-02-10
NKTRRobin Howard WPres, CEOS - Sale+OE$11.49-66,66610,410-86%-$765,9920-1+13+50
D
2016-01-19
NKTRThomsen Jillian B.SVP, Chief Accounting OfficerS - Sale+OE$14.12-15,0003,999-79%-$211,800+3+1-20+7
D
2016-01-19
NKTRRobin Howard WPres, CEOS - Sale+OE$14.12-66,66710,410-86%-$941,338+3+1-20+7
D
2016-01-20
NKTRLingnau LutzDirS - Sale+OE$14.51-15,00016,450-48%-$217,650+3+1-20+7
D
2016-01-19
NKTRLabrucherie Gil MSVP, GCS - Sale+OE$14.12-11,6675,251-69%-$164,738+3+1-20+7
D
2015-12-03
NKTRLabrucherie Gil MSVP, GCS - Sale+OE$15.87-45,0015,251-90%-$714,16600+2+4
D
2015-12-03
NKTRRobin Howard WPres, CEOS - Sale+OE$15.87-125,00110,410-92%-$1,983,76600+2+4
D
2015-12-04
NKTRKuebler Christopher ADirS - Sale+OE$15.82-15,00020,000-43%-$237,30000+2+4
D
2015-12-03
NKTRThomsen Jillian B.SVP, Chief Accounting OfficerS - Sale+OE$15.87-15,0003,999-79%-$238,05000+2+4

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top